Evidence map›Paper›PMID 21448379›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2011

Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial.

Shaghayegh Haghjooy Javanmard, Seyed Ali Sonbolestan, Kian Heshmat-Ghahdarijani, Mohamad Saadatnia, Seyed Ahamad Sonbolestan

Open access · greenAbstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Peripheral vascular dysfunction in migraine: a review.The journal of headache and pain · 2013
    Review
  6. Mutation analysis of CACNA1A gene in Iranian migrainous and review literatures.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  7. Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shaghayegh Haghjooy JavanmardApplied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed Ali Sonbolestan
Kian Heshmat-Ghahdarijani
Mohamad Saadatnia
Seyed Ahamad Sonbolestan
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are increasing evidences of endothelial dysfunction in migraine. The ACE-inhibitors have previously been shown to be effective in migraine prophylaxis. Furthermore, ACE inhibitors have beneficial effects on endothelial dysfunction. We therefore investigated whether Enalapril is effective in endothelial function improvement.

methodsIn this randomized clinical trial, 10 mg Enalapril daily was compared with matched placebo in 40 patients with migraine for two months. Flow Mediated Dilation (FMD), serum total nitrite and C-reactive protein (CRP) were measured in all patients at the baseline and after 2 months.

resultspatients' FMD increased in the case group after treatment with Enalapril (p = 0.002) while there was no significant change in control group. Total nitrite concentration increased in case group (p = 0.000), while there was no significant difference before treatment. There was no significant difference in the CRP concentrations in two groups.

conclusionsThese results indicate that ACE inhibition can improve endothelial function in patients with migraine, as it has been shown by both FMD and serum levels of nitric oxide. The mechanism could be either that Enalapril limits the angiotensin IIinduced production of superoxide radicals which would normally inactivate nitric oxide, or that it may increase bradykinin-mediated nitric oxide release.

Indexed as

C-Reactive ProteinEndotheliumMigraine DisordersNitrites

Identifiers

PMID21448379
PMCPMC3063439
OpenAlexW2110302023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.